Cypress Point Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-720
Closed -$153K 37
2021
Q3
$153K Hold
720
0.11% 32
2021
Q2
$176K Buy
+720
New +$177K 0.13% 32

Other funds holding AMGN

Cypress Point Wealth Management's AMGN Position: Q4 2021 in Review

Cypress Point Wealth Management sold out of Amgen (AMGN) in Q4 2021, closing a stake of 720 shares — an estimated $153K sold.

Cypress Point Wealth Management first reported a position in AMGN in Q2 2021 and held it in 2 quarters. The position peaked at $176K in Q2 2021. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Cypress Point Wealth Management reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • Cypress Point Wealth Management sold 720 Amgen shares in Q4 2021, an estimated $153K.
  • Cypress Point Wealth Management first reported a position in Amgen in Q2 2021 and held it in 2 quarters.
  • Cypress Point Wealth Management's Amgen position peaked at $176K in Q2 2021.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Cypress Point Wealth Management's 13F filing for Q4 2021, filed 27 Jan 2022.